Clinical trials
Phase 2/3 Coronary Artery Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital of Harbin Medical University | 2 |
| Boston Scientific Corporation | 1 |
| CSL Behring | 1 |
| Gold, Herman K., MD | 1 |
| Joslin Diabetes Center | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Northwestern University | 1 |
| Point Biomedical | 1 |
| Tufts University | 1 |
| VA Office of Research and Development | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 11 |
| Atherosclerosis | 2 |
| Diabetes Mellitus | 2 |
| Acute Coronary Syndrome | 1 |
| Acute Kidney Injury | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Disease | 1 |
| Heart Diseases | 1 |
| Heart Failure | 1 |
| Hyperlipoproteinemia Type II | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.